Skip to main content
PEPTARA LABS
Get Started

Tirzepatide Half Life

Tirzepatide Half Life

Published by · Updated · How we research and check our pages

The short answer

Tirzepatide half life is about 5 days, an elimination half-life reported in the tirzepatide prescribing information (FDA). Tirzepatide binds extensively to plasma albumin, which slows its clearance (tirzepatide prescribing information, FDA).

This page is general educational information, research-use framing only, not medical advice. Research-grade tirzepatide is supplied for laboratory research only, not for human use.

What is the half life of tirzepatide?

Tirzepatide has an elimination half-life of about 5 days, according to the tirzepatide prescribing information (FDA).

Half-life is the time it takes for the amount of a compound in the blood to fall by half. A 5-day figure is long for a peptide. Tirzepatide binds extensively to plasma albumin, a protein that circulates in blood, which slows its clearance and stretches the half-life (tirzepatide prescribing information, FDA).

Because the half-life is measured across a study population, the real value for any single person shifts with body weight, kidney and liver function, and other factors. The 5-day number is a population average, not a fixed value.

What does a 5-day half life mean?

A half-life of about 5 days means the amount of tirzepatide in the blood falls by half roughly every 5 days, so it clears over weeks rather than hours.

After one half-life (about 5 days), roughly half of the amount remains; after two, about a quarter; after four to five, only a few percent.

What PK values does the prescribing information report?

The tirzepatide prescribing information (FDA) reports an elimination half-life of about 5 days and a time to peak concentration of 8 to 72 hours after administration.

ParameterReported valueSource
Elimination half-lifeabout 5 daysTirzepatide prescribing information (FDA)
Time to peak concentration8 to 72 hours after administrationTirzepatide prescribing information (FDA)

How does tirzepatide half life compare to semaglutide?

Both are long-acting peptides; tirzepatide's half-life is about 5 days.

CompoundHalf-lifeReported weight outcome
Tirzepatideabout 5 days (tirzepatide prescribing information, FDA)up to about 22.5 percent (Jastreboff et al., 2022)
Semaglutidelong-acting (Wilding et al., 2021)about 15 percent (Wilding et al., 2021)

In a head-to-head trial, tirzepatide produced greater weight and glucose reductions than semaglutide (Frias et al., 2021). Half-life alone does not decide outcomes; it describes how long a compound stays in circulation, not the size of the effect.

How quickly does tirzepatide clear after administration ends?

Slowly. With a 5-day half-life, tirzepatide takes roughly 3 to 4 weeks to clear almost completely after administration ends, and trials show weight tends to return as levels fall.

A general pharmacology rule is that a compound is almost fully cleared after about 4 to 5 half-lives. About 20 to 25 days after administration ends, blood levels are near zero. As the drug effect fades, appetite signaling drifts back toward its prior baseline. In SURMOUNT-4, participants who stopped tirzepatide regained a large share of the weight they had lost (Aronne et al., 2024), and a similar pattern followed semaglutide withdrawal in the STEP 1 extension (Wilding et al., 2022). Part of this reflects adaptive thermogenesis, the body's tendency to defend a higher weight after loss (Rosenbaum and Leibel, 2010). This is loss of drug effect over time, not a defect in the compound.

Tirzepatide Half Life: FAQ

What is tirzepatide's half life in days?

About 5 days, according to the tirzepatide prescribing information (FDA).

How long does tirzepatide persist after administration ends?

Roughly 3 to 4 weeks. Clearance takes about 4 to 5 half-lives, and the half-life is about 5 days (tirzepatide prescribing information, FDA), so blood levels are near zero after about 20 to 25 days.

Sourcing research-grade peptides?

Talk to the Peptara Labs team about purity, third-party certificates of analysis, and cold-chain shipping.

General educational information only, research-use framing, not medical advice. Research material is for laboratory research only, not for human use.

Chat with us